Outgoing CEO: Perrigo Outfitted To Sail On OTC, Rx And Euro Growth

Hendrickson recounts Perrigo's strategies to right the ship after a hole in earnings opened from investing in a European consumer health business and operating API and dietary supplement divisions and as pricing pressures on generic drugs took some wind out of its revenue sails.

Perrigo Co. PLC CEO John Hendrickson says his successor will take the helm of a firm "positioned in exactly the right place" to grow after trimming businesses competing in markets outside its core areas of consumer health products and Rx generics.

Uwe Rohrhoff's plans for Perrigo's Rx generics business after he starts as president and CEO on Jan. 15 (see sidebar...